Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6937827 | 0.93 | RECQL (0.53) | CYP1A2CYP3A4CYP2C9CYP2C19PKM | |
| SCHEMBL10552333 | 0.90 | L3MBTL1 (0.59) | CYP1A2CYP3A4CYP2C9CYP2C19PKM | |
| SCHEMBL27528801 | 0.89 | MTNR1A (0.53) | CYP1A2CYP3A4CYP2C9CYP2C19PKM | |
| SCHEMBL11577655 | 0.86 | HDAC1 (0.65) | KCNA3HDAC1HDAC2 | |
| SCHEMBL11617521 | 0.86 | HDAC1 (0.65) | KCNA3HDAC1HDAC2 | |
| SCHEMBL11780338 | 0.86 | CYP1A2 (0.56) | CYP1A2CYP3A4CYP2C9CYP2C19PKM | |
| SCHEMBL14317565 | 0.86 | MTNR1A (0.50) | CYP1A2CYP3A4CYP2C9CYP2C19PKM | |
| SCHEMBL4589730 | 0.84 | CYP1A2 (0.54) | CYP1A2CYP3A4CYP2C9CYP2C19PKM | |
| SCHEMBL1811389 | 0.84 | RAB9A (0.59) | CYP1A2CYP3A4CYP2C9CYP2C19RECQL | |
| SCHEMBL27888911 | 0.83 | RAB9A (0.55) | RECQLTSHRALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117583025-A | High-selectivity anisole acetylation reaction solid acid catalyst and application method thereof | 浙江环化科技有限公司 | 2024-02-23 | — | — | CN | disclosed |
| US-20040102654-A1 | Process facilitating the regeneration of a catalyst based on a zeolite used in an acylation reaction, catalyst and use | SPAGNOL MICHEL (FR) | 2004-05-27 | — | — | US | disclosed |
| EP-0972776-B1 | A phosphine sulfide, a manufacturing process therefor and a use thereof | MITSUI CHEMICALS INC (JP) | 2003-04-23 | — | — | EP | disclosed |
| US-20020120169-A1 | Process facilitating the regeneration of a catalyst based on a zeolite used in an acylation reaction, catalyst and use | SPAGNOL MICHEL (FR) | 2002-08-29 | — | — | US | disclosed |
| US-6194616-B1 | MIXING AROMATIC COMPOUND AND ACYLATION COMPOUND FORMING REACTION MIXTURE; PASSING MIXTURE OVER CATALYTIC BED COMPRISING ZEOLITE; RECIRCULATING REACTION MIXTURE FROM CATALYTIC BED OVER CATALYTIC BED | RHODIA CHIMIE (FR) | 2001-02-27 | — | — | US | disclosed |
| US-6153794-A | Phosphine sulfide, a manufacturing process therefor and use thereof | MITSUI CHEMICALS, INC. (JP) | 2000-11-28 | — | — | US | disclosed |
| CN-1262276-A | Phosphine sulfide preparing process and use thereof | MITSUI CHEMICALS INC (JP) | 2000-08-09 | — | — | CN | disclosed |
| EP-0972776-A1 | A phosphine sulfide, a manufacturing process therefor and a use thereof | Mitsui Chemicals, Inc. (JP) | 2000-01-19 | — | — | EP | disclosed |
| US-4855460-A | ZINC OR CADMIUM CATALYST | RHONE-POULENC CHIMIE (FR) | 1989-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020120169-A1 | Process facilitating the regeneration of a catalyst based on a zeolite used in an acylation reaction, catalyst and use | AFF4, APEH, TECR | CYP1A2 942/4885CYP3A4 487/4885CYP2C9 1103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.